Tertiary Hyperparathyroidism Resistant to Cinacalcet Treatment
Version of Record online: 19 MAY 2011
© 2011 The Authors. Therapeutic Apheresis and Dialysis © 2011 International Society for Apheresis
Therapeutic Apheresis and Dialysis
Special Issue: Recent Advances in CKD-MBD Research - Masafumi Fukagawa and Tadao Akizawa, Guest Editors. The publication of this supplement has been supported by Chugai Pharmaceutical Co., Ltd
Volume 15, Issue Supplement s1, pages 33–37, June 2011
How to Cite
Okada, M., Tominaga, Y., Izumi, K., Nobata, H., Yamamoto, T., Hiramitsu, T., Tsujita, M., Goto, N., Nanmoku, K., Watarai, T. and Uchida, K. (2011), Tertiary Hyperparathyroidism Resistant to Cinacalcet Treatment. Therapeutic Apheresis and Dialysis, 15: 33–37. doi: 10.1111/j.1744-9987.2011.00924.x
- Issue online: 19 MAY 2011
- Version of Record online: 19 MAY 2011
- Received January 2011; revised January 2011.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.